Back to Search
MICHAEL KARKKAINEN, DO
DO
Surgery Physician
NPI: 1821199100IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
38276(WI)
CMS Specialties
PrimaryGENERAL SURGERY
Education
MICHIGAN STATE UNIVERSITY COLLEGE OF OSTEOPATHIC MEDICINE
Class of 1991
Research & Publications (20)
Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
PMID 14634646·Nat Immunol·2004
7-preclinical
Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis.
PMID 11969367·Semin Cell Dev Biol·2002
6-review
A model for gene therapy of human hereditary lymphedema.
PMID 11592985·Proc Natl Acad Sci U S A·2001
7-preclinical
Molecular regulation of lymphangiogenesis and targets for tissue oedema.
PMID 11427983·Trends Mol Med·2001
6-review
Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis.
PMID 11114740·Oncogene·2000
6-review
Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.
PMID 10835628·Nat Genet·2000
7-preclinical
Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos.
PMID 18519586·Mol Cell Biol·2008
7-preclinical
Selenium speciation and bioavailability in biofortified products using species-unspecific isotope dilution and reverse phase ion pairing-inductively coupled plasma-mass spectrometry.
PMID 18254593·J Agric Food Chem·2008
8-other
Transcapillary fluid balance consequences of missing initial lymphatics studied in a mouse model of primary lymphoedema.
PMID 16675495·J Physiol·2006
4-observational
VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain.
PMID 16462734·Nat Neurosci·2006
7-preclinical
Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.
PMID 15207507·Trends Immunol·2004
6-review
Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis.
PMID 15172976·Cancer Res·2004
7-preclinical
Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites.
PMID 12881528·J Biol Chem·2003
7-preclinical
Insights into the molecular pathogenesis and targeted treatment of lymphedema.
PMID 12543720·Ann N Y Acad Sci·2002
6-review
Adenovirus-mediated extracellular superoxide dismutase gene therapy reduces neointima formation in balloon-denuded rabbit aorta.
PMID 12370226·Circulation·2002
7-preclinical
Abnormal lymphatic vessel development in neuropilin 2 mutant mice.
PMID 12361971·Development·2002
7-preclinical
Lymphangiogenic gene therapy with minimal blood vascular side effects.
PMID 12235206·J Exp Med·2002
7-preclinical
Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes.
PMID 12087065·FASEB J·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3003 UNIVERSITY DR
MARINETTE, WI 54143 - Phone
- (715) 735-8056
Quick Facts
- NPI
- 1821199100
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile